OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2(+) breast cancer patients

OBJECTIVE: This study aimed to evaluate the correlations of expression of OCT4, SOX2, and NANOG with clinicopathological features and overall survival (OS) in human epidermal growth factor receptor 2-positive (HER2(+)) breast cancer (BC) patients. METHODS: One hundred and thirty-four surgical HER2(+...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fan, Zhang, Jiaming, Yang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6228048/
https://www.ncbi.nlm.nih.gov/pubmed/30464534
http://dx.doi.org/10.2147/OTT.S173522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6228048/
https://www.ncbi.nlm.nih.gov/pubmed/30464534
http://dx.doi.org/10.2147/OTT.S173522

Ejemplares similares